ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

ACRS Aclaris Therapeutics Inc

1.38
0.07 (5.34%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Aclaris Therapeutics Inc ACRS NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.07 5.34% 1.38 09:00:00
始値 安値 高値 終値 前日終値
1.31 1.31 1.40 1.36 1.31
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/3020:00GLOBEAclaris Therapeutics to Announce First Quarter 2024..
2024/4/2321:00PRNUSFlare Therapeutics Appoints Douglas Manion, M.D., FRCP (C)..
2024/3/0607:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0607:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0607:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2721:30EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/2721:14EDGAR2Form 8-K - Current report
2024/2/2721:00GLOBEAclaris Therapeutics Reports Fourth Quarter and Full Year..
2024/2/1510:32EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1504:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1404:24EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0609:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0609:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0609:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0609:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0606:31EDGAR2Form 8-K/A - Current report: [Amend]
2024/2/0606:30EDGAR2Form 8-K - Current report
2024/1/1921:30EDGAR2Form 8-K - Current report
2024/1/1621:00GLOBEAclaris Therapeutics Announces Leadership Changes and..
2024/1/1021:00GLOBEAclaris Therapeutics Announces Top-line Results from 4-Week..
2024/1/0406:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0406:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2006:15EDGAR2Form 8-K - Current report
2023/12/2006:01GLOBEAclaris Therapeutics Provides Corporate Update
2023/12/0606:01GLOBEAclaris Therapeutics Announces Patent License Agreement with..
2023/11/1321:42EDGAR2Form 8-K - Current report
2023/11/1321:00GLOBEAclaris Therapeutics Announces Top-line Results from 12-Week..
2023/11/0621:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0621:15EDGAR2Form 8-K - Current report
2023/11/0621:00GLOBEAclaris Therapeutics Reports Third Quarter 2023 Financial..
2023/10/2605:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/2405:06EDGAR2Form 144 - Report of proposed sale of securities
2023/10/0320:00GLOBEAclaris Therapeutics Completes Enrollment in Phase 2b Study..
2023/9/2020:00GLOBEAclaris Therapeutics to Participate in the 2023 Cantor..
2023/9/1821:00EDGAR2Form 8-K - Current report
2023/9/1820:00GLOBEAclaris Therapeutics Announces Positive Results from Phase 1..
2023/9/0805:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/0606:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2905:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2305:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2205:20EDGAR2Form 144 - Report of proposed sale of securities
2023/8/0720:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0720:15EDGAR2Form 8-K - Current report
2023/8/0720:00GLOBEAclaris Therapeutics Reports Second Quarter 2023 Financial..
2023/8/0405:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/0605:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/6/1320:01GLOBEAclaris Therapeutics Completes Enrollment in Phase 2b Study..
2023/6/0220:00GLOBEAclaris Therapeutics to Participate in Two June Healthcare..
2023/5/0820:00GLOBEAclaris Therapeutics Reports First Quarter 2023 Financial..

最近閲覧した銘柄

Delayed Upgrade Clock